BMEA vs VRTX
Biomea Fusion Inc (BMEA) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BMEA currently screens at market cap $94.7M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BMEA and VRTX stock pages for the full models.
Not investment advice.